BTAI
Price
$2.71
Change
+$0.09 (+3.44%)
Updated
Oct 15, 11:15 AM (EDT)
Capitalization
51.67M
Intraday Buy/Sell Signals
TENX
Price
$7.51
Change
+$0.10 (+1.35%)
Updated
Oct 14 closing price
Capitalization
33.9M
Intraday Buy/Sell Signals
Interact to see
Advertisement

BTAI vs TENX

Header iconBTAI vs TENX Comparison
Open Charts BTAI vs TENXBanner chart's image
BioXcel Therapeutics
Price$2.71
Change+$0.09 (+3.44%)
Volume$1.81K
Capitalization51.67M
Tenax Therapeutics
Price$7.51
Change+$0.10 (+1.35%)
Volume$65.84K
Capitalization33.9M
BTAI vs TENX Comparison Chart in %
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BTAI vs. TENX commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTAI is a Hold and TENX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (BTAI: $2.62 vs. TENX: $7.51)
Brand notoriety: BTAI and TENX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BTAI: 16% vs. TENX: 83%
Market capitalization -- BTAI: $51.67M vs. TENX: $33.9M
BTAI [@Biotechnology] is valued at $51.67M. TENX’s [@Biotechnology] market capitalization is $33.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BTAI’s FA Score shows that 0 FA rating(s) are green whileTENX’s FA Score has 1 green FA rating(s).

  • BTAI’s FA Score: 0 green, 5 red.
  • TENX’s FA Score: 1 green, 4 red.
According to our system of comparison, TENX is a better buy in the long-term than BTAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BTAI’s TA Score shows that 6 TA indicator(s) are bullish while TENX’s TA Score has 5 bullish TA indicator(s).

  • BTAI’s TA Score: 6 bullish, 4 bearish.
  • TENX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BTAI is a better buy in the short-term than TENX.

Price Growth

BTAI (@Biotechnology) experienced а +4.80% price change this week, while TENX (@Biotechnology) price change was +0.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BTAI($51.7M) has a higher market cap than TENX($33.9M). TENX YTD gains are higher at: 21.325 vs. BTAI (-56.205). TENX has higher annual earnings (EBITDA): -31.48M vs. BTAI (-34.61M). TENX has more cash in the bank: 105M vs. BTAI (17.4M). TENX has less debt than BTAI: TENX (413K) vs BTAI (109M). BTAI has higher revenues than TENX: BTAI (868K) vs TENX (0).
BTAITENXBTAI / TENX
Capitalization51.7M33.9M153%
EBITDA-34.61M-31.48M110%
Gain YTD-56.20521.325-264%
P/E RatioN/A2.53-
Revenue868K0-
Total Cash17.4M105M17%
Total Debt109M413K26,392%
FUNDAMENTALS RATINGS
BTAI vs TENX: Fundamental Ratings
BTAI
TENX
OUTLOOK RATING
1..100
5127
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6338
P/E GROWTH RATING
1..100
10083
SEASONALITY SCORE
1..100
9034

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TENX's Valuation (27) in the Medical Specialties industry is somewhat better than the same rating for BTAI (70) in the Biotechnology industry. This means that TENX’s stock grew somewhat faster than BTAI’s over the last 12 months.

TENX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as BTAI (100) in the Biotechnology industry. This means that TENX’s stock grew similarly to BTAI’s over the last 12 months.

TENX's SMR Rating (98) in the Medical Specialties industry is in the same range as BTAI (100) in the Biotechnology industry. This means that TENX’s stock grew similarly to BTAI’s over the last 12 months.

TENX's Price Growth Rating (38) in the Medical Specialties industry is in the same range as BTAI (63) in the Biotechnology industry. This means that TENX’s stock grew similarly to BTAI’s over the last 12 months.

TENX's P/E Growth Rating (83) in the Medical Specialties industry is in the same range as BTAI (100) in the Biotechnology industry. This means that TENX’s stock grew similarly to BTAI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BTAITENX
RSI
ODDS (%)
Bullish Trend 8 days ago
89%
Bearish Trend 8 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 8 days ago
83%
Bearish Trend 8 days ago
88%
Momentum
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 8 days ago
82%
MACD
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 13 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 8 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 8 days ago
90%
Bullish Trend 8 days ago
78%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 15 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 8 days ago
90%
Aroon
ODDS (%)
Bearish Trend 8 days ago
90%
Bullish Trend 8 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUID2.710.06
+2.26%
authID
CVS79.661.22
+1.56%
CVS HEALTH Corp
PENG22.560.24
+1.08%
Penguin Solutions Inc
CWAN17.900.07
+0.39%
Clearwater Analytics Holdings
SMC20.26-0.15
-0.73%
Summit Midstream Corporation

BTAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BTAI has been loosely correlated with TENX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BTAI jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BTAI
1D Price
Change %
BTAI100%
+0.38%
TENX - BTAI
37%
Loosely correlated
+1.35%
SYBX - BTAI
37%
Loosely correlated
+10.32%
SBHMY - BTAI
32%
Poorly correlated
N/A
CRMD - BTAI
29%
Poorly correlated
-0.38%
CASI - BTAI
28%
Poorly correlated
-4.23%
More

TENX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TENX has been loosely correlated with CMVLF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if TENX jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TENX
1D Price
Change %
TENX100%
+1.35%
CMVLF - TENX
56%
Loosely correlated
N/A
AVXL - TENX
45%
Loosely correlated
+2.03%
INTI - TENX
44%
Loosely correlated
N/A
ABCZF - TENX
43%
Loosely correlated
N/A
CORT - TENX
38%
Loosely correlated
+0.82%
More